Literature DB >> 31329370

Leishmania species-dependent functional duality of toll-like receptor 2.

Abdollah Jafarzadeh1,2, Maryam Nemati2,3, Iraj Sharifi4, Arathi Nair5, Divanshu Shukla5, Prashant Chauhan5, Hossain Khorramdelazad2, Arup Sarkar6, Bhaskar Saha5,6.   

Abstract

Toll-like receptors (TLRs) are a subset of pattern recognition receptors (PRR) in innate immunity and act as a connecting link between innate and adaptive immune systems. During Leishmania infection, the activation of TLRs influences the pathogen-specific immune responses, which may play a decisive role in determining the outcome of infection, toward elimination or survival of the pathogen. Antigen-presenting cells (APCs) of the innate immune system such as macrophages, dendritic cells (DCs), neutrophils, natural killer (NK) cells, and NKT cells express TLR2, which plays a crucial role in the parasite recognition and elicitation of immune responses in Leishmania infection. Depending on the infecting Leishmania species, the TLR2 pathways may result in a host-protective or a disease-exacerbating response. While Leishmania major and Leishmania donovani infections trigger TLR2-related host-protective and non-protective immune responses, Leishmania mexicana and Leishmania infantum infections are reported to elicit TLR2-mediated host-protective responses and Leishmania amazonensis and Leishmania braziliensis infections are reported to evoke a disease-exacerbating response. These findings illustrate that TLR2-related effector functions are diverse and may be exerted in a species- or strain-dependent manner. TLR2 agonists or antagonists may have therapeutic potentials to trigger the desired immune response during leishmaniasis. In this review, we discuss the TLR2-related immune responses during leishmaniasis and highlight the novel insights into the possible role of TLR2-driven resistance or susceptibility to Leishmania.
© 2019 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  zzm321990Leishmania; TLR2; immune response; resistance; susceptibility

Mesh:

Substances:

Year:  2019        PMID: 31329370     DOI: 10.1002/iub.2129

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  6 in total

1.  TLR2 dimer-specific ligands selectively activate protein kinase C isoforms in Leishmania infection.

Authors:  Arkajyoti Mukherjee; Sayoni Roy; Ashok Patidar; Neelam Bodhale; Jagneswar Dandapat; Bhaskar Saha; Arup Sarkar
Journal:  Immunology       Date:  2021-06-07       Impact factor: 7.215

2.  Interdependencies between Toll-like receptors in Leishmania infection.

Authors:  Divanshu Shukla; Ashok Patidar; Uddipan Sarma; Prashant Chauhan; Surya Prakash Pandey; Himanshu Singh Chandel; Neelam Bodhale; Soumya Kanti Ghosh; Carlos Alberto Guzman; Thomas Ebensen; Ricardo Silvestre; Arup Sarkar; Bhaskar Saha; Surajit Bhattacharjee
Journal:  Immunology       Date:  2021-05-26       Impact factor: 7.215

Review 3.  Bidirectional cytokine-microRNA control: A novel immunoregulatory framework in leishmaniasis.

Authors:  Abdollah Jafarzadeh; Maryam Nemati; Najmeh Aminizadeh; Neelam Bodhale; Arup Sarkar; Sara Jafarzadeh; Iraj Sharifi; Bhaskar Saha
Journal:  PLoS Pathog       Date:  2022-08-04       Impact factor: 7.464

Review 4.  Determinants of Unresponsiveness to Treatment in Cutaneous Leishmaniasis: A Focus on Anthroponotic Form Due to Leishmania tropica.

Authors:  Mehdi Bamorovat; Iraj Sharifi; Razieh Tavakoli Oliaee; Abdollah Jafarzadeh; Ahmad Khosravi
Journal:  Front Microbiol       Date:  2021-06-01       Impact factor: 5.640

Review 5.  Interleukin-27 Functional Duality Balances Leishmania Infectivity and Pathogenesis.

Authors:  Abdollah Jafarzadeh; Maryam Nemati; Prashant Chauhan; Ashok Patidar; Arup Sarkar; Iraj Sharifi; Bhaskar Saha
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

6.  Toll-Like Receptors 2, 4, and 7, Interferon-Gamma, Interleukin 10, and Programmed Death Ligand 1 Transcripts in Leishmanin Skin Test-Positive Reactions of Ibizan Hound Dogs.

Authors:  Laura Ordeix; Sara Montserrat-Sangrà; Pamela Martínez-Orellana; Laia Solano-Gallego
Journal:  J Immunol Res       Date:  2020-03-10       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.